Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Le Kremlin-Bicetre – page 14

297 clinical trials in Le Kremlin-Bicetre, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Le Kremlin-Bicetre at a glance
297
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

297 trials in Le Kremlin-Bicetre

Open in trial search

Abortion threatened

Not yet recruiting

Comparison of ceftriaxone and azithromycin versus amoxicillin and azithromycin for pregnant women with preterm premature rupture of membranes between 22 and 33 weeks.

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Amoxicillin
  • Sponsor:Assistance Publique Hopitaux De Paris

Craniopharyngioma

Not yet recruiting

A study to evaluate the effectiveness of semaglutide for treating obesity caused by craniopharyngioma in children aged 12 to 17 years.

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Semaglutide
  • Sponsor:Centre Hospitalier Universitaire D'Angers

Colitis ulcerative

Not yet recruiting

A study comparing vedolizumab, filgotinib, ustekinumab, and infliximab to maintain remission in patients with ulcerative colitis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Filgotinib
  • Sponsor:University Hospital Of Clermont-Ferrand

Ischaemic stroke

Not yet recruiting

Comparing tenecteplase and mechanical clot removal versus mechanical clot removal alone for adults with a large ischemic stroke

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Assistance Publique Hopitaux De Paris

Hypoparathyroidism

Not yet recruiting

A study to evaluate the safety and effects of palopegteriparatide in adolescents with chronic hypoparathyroidism

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Palopegteriparatide
  • Sponsor:Ascendis Pharma Bone Diseases A/S

Study of the effects of Ibutamoren Mesilate in prepubertal children with growth hormone deficiency

Investigational
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Ibutamoren Mesilate
  • Sponsor:Lumos Pharma Inc.

Comparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Etoposide
  • Sponsor:Assistance Publique Hopitaux De Paris

Thrombosis prophylaxis

Not yet recruiting

Comparing intermediate and standard doses of enoxaparin to prevent blood clots in patients with severe trauma

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Chemical burn

Not yet recruiting

Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Fondation A De Rothschild

Testing avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avacopan
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Systemic candida

Not yet recruiting

Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anidulafungin
  • Sponsor:Assistance Publique Hopitaux De Paris

Acquired ATTR amyloidosis

Not yet recruiting

A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acoramidis Hydrochloride
  • Sponsor:Eidos Therapeutics Inc.

Other cities in France

The busiest research cities in the country

All 380 cities in France

Clinical research in Le Kremlin-Bicetre

What the registry says about research in the country

01 Gastroenterology Research

Innovative studies exploring treatments for inflammatory bowel diseases, with multiple trials investigating fecal microbiota transplantation as a therapeutic approach for Crohn's disease and ulcerative colitis. Research focuses on maintaining remission and improving patient outcomes.

  • Crohn's Disease Management
  • Ulcerative Colitis Treatment
  • Microbiota-Based Therapies
02 Neurology Studies

Clinical research targeting neurological conditions, including trials for Myasthenia Gravis and innovative treatments for aneurysmal subarachnoid hemorrhage. Studies aim to improve daily living activities and patient outcomes.

  • Myasthenia Gravis Treatment
  • Subarachnoid Hemorrhage Management
  • Neurological Disorders
03 Immunology & Rheumatology

Comprehensive research into autoimmune conditions, including studies on rheumatoid arthritis and Sjögren's syndrome. Trials evaluate novel therapeutic approaches and maintenance treatments for improved disease management.

  • Rheumatoid Arthritis Therapies
  • Sjögren's Syndrome Research
  • Immune System Disorders
04 Pulmonary Medicine

Advanced research in respiratory conditions, including studies on pulmonary hypertension, severe asthma, and interstitial lung disease. Trials focus on evaluating new treatments and improving patient care strategies.

  • Pulmonary Hypertension
  • Severe Asthma Management
  • Lung Fibrosis Treatment
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.